x min read

Active Stocks to Watch: Denbury Resources Inc. (NYSE:DNR), Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Verizon Communications Inc. (NYSE:VZ), The Medicines Company (NASDAQ:MDCO), Sizmek (NASDAQ:SZMK)

Active Stocks to Watch: Denbury Resources Inc. (NYSE:DNR), Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Verizon Communications Inc. (NYSE:VZ), The Medicines Company (NASDAQ:MDCO), Sizmek (NASDAQ:SZMK)
Written by
Charles Donlon
Published on
November 5, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Denbury Resources Inc. (NYSE:DNR) reports Q3 (Sep) earnings of $0.26 per share, excluding non-recurring items, in-line with the Capital IQ Consensus Estimate of $0.26; revenues fell 6.1% year/year to $633 mln vs the $625.38 mln consensus. Denbury Resources Inc. (NYSE:DNR) belongs to Basic Materials sector. Its net profit margin is 7.50% and weekly performance is -9.11%. On last trading day company shares ended up $11.28. Denbury Resources Inc. (NYSE:DNR) distance from 50-day simple moving average (SMA50) is -22.42%. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) announced that Patrick Vink, M.D., M.B.A., currently Senior Vice President and General Manager of Cubist's International Business, has been promoted to Executive Vice President and Chief Operating Officer, effective January 1, 2015. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) shares fell -0.90% in last trading session and ended the day at $72.42. CBST Gross Margin is 71.00% and its return on assets is 2.10%. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) quarterly performance is 17.81%. BroadSoft (BSFT) announced that Verizon Communications Inc. (NYSE:VZ) has selected BroadSoft's BroadWorks Telephony Application Server to deliver business communication services targeted to Verizon's fixed and mobile subscribers. On 04 November, Verizon Communications Inc. (NYSE:VZ) shares decreased -0.12% and was closed at $50.33. VZ EPS growth in last 5 year was 48.40%. Verizon Communications Inc. (NYSE:VZ) year to date (YTD) performance is 6.99%.The Medicines Company (NASDAQ:MDCO) announced enrollment of the first patient in its Phase 3 clinical trial program for CARBAVANCE, an investigational intravenous antibiotic under development for the treatment of serious bacterial infections due to gram-negative bacteria. The Medicines Company (NASDAQ:MDCO) ended the last trading day at $25.59. Company weekly volatility is calculated as 4.01% and price to cash ratio as 4.53. The Medicines Company (NASDAQ:MDCO) showed a weekly performance of -1.04%. Sizmek Inc. (NASDAQ:SZMK) launched a self-serve toolset for building and distributing rich media ads across major social properties on any device. Sizmek Inc. (NASDAQ:SZMK) shares fell -3.63% in last trading session and ended the day at $5.57. SZMK Gross Margin is 66.00% and its return on assets is -3.30%. Sizmek Inc. (NASDAQ:SZMK) quarterly performance is -40.43%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.